Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Abvc Biopharma (ABVC) over the last 9 years, with Q3 2025 value amounting to -$95919.0.

  • Abvc Biopharma's Other Working Capital Changes rose 344.57% to -$95919.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$144253.0, marking a year-over-year increase of 8002.03%. This contributed to the annual value of -$168896.0 for FY2024, which is 5199.9% up from last year.
  • Abvc Biopharma's Other Working Capital Changes amounted to -$95919.0 in Q3 2025, which was up 344.57% from -$74135.0 recorded in Q2 2025.
  • Abvc Biopharma's 5-year Other Working Capital Changes high stood at $203621.0 for Q1 2023, and its period low was -$1.0 million during Q3 2022.
  • For the 4-year period, Abvc Biopharma's Other Working Capital Changes averaged around -$151711.8, with its median value being -$100182.0 (2024).
  • As far as peak fluctuations go, Abvc Biopharma's Other Working Capital Changes tumbled by 855314.7% in 2023, and later soared by 13157.37% in 2024.
  • Abvc Biopharma's Other Working Capital Changes (Quarter) stood at $4973.0 in 2022, then tumbled by 8553.15% to -$420375.0 in 2023, then skyrocketed by 131.57% to $132728.0 in 2024, then plummeted by 172.27% to -$95919.0 in 2025.
  • Its last three reported values are -$95919.0 in Q3 2025, -$74135.0 for Q2 2025, and -$106927.0 during Q1 2025.